Secukinumab for the Treatment of Psoriatic Arthritis: Comparative Effectiveness Versus Adalimumab Using a Matching-Adjusted Indirect Comparison

被引：0
作者：
Nash, Peter [1 ]
McInnes, Iain B. [2 ]
Mease, Philip J. [3 ,4 ]
Choy, Ernest H. [5 ,6 ]
Thom, Howard [7 ]
Kalyvas, Chrysostomos [8 ]
Gandhi, Kunal [9 ]
Mpofu, Shephard [10 ]
Jugl, Steffen [10 ]
机构：
[1] Univ Queensland, Dept Med, Brisbane, Qld, Australia
[2] Univ Glasgow, Glasgow, Lanark, Scotland
[3] Swedish Med Ctr, Seattle, WA USA
[4] Univ Washington, Seattle, WA 98195 USA
[5] Cardiff Univ, Sch Med, Rheumatol Sect, Cardiff, S Glam, Wales
[6] Cardiff Univ, CREATE Ctr, Div Infect & Immun, Cardiff, S Glam, Wales
[7] Univ Bristol, Bristol, Avon, England
[8] MAPI Grp, Houten, Netherlands
[9] Novartis Pharmaceut, E Hanover, NJ USA
[10] Novartis Pharma AG, Basel, Switzerland
来源：
ARTHRITIS & RHEUMATOLOGY | 2016年 / 68卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1738
引用
收藏
页数：2
相关论文
共 50 条
[21]   SECUKINUMAB SHOWS HIGHER SYMPTOMATIC IMPROVEMENT VERSUS ETANERCEPT IN PSORIATIC ARTHRITIS: COMPARATIVE EFFECTIVENESS UP TO 24 WEEKS ASSESSED BY MATCHING-ADJUSTED INDIRECT COMPARISON [J].
Mease, P. ;
Choy, E. ;
Thom, H. ;
Kalyvas, C. ;
Lopes, N. ;
Pricop, L. ;
Gandhi, K. ;
Jugl, S. M. ;
Nash, P. .
VALUE IN HEALTH, 2017, 20 (09) :A936-A936
[22]   RELATIVE EFFICACY OF ADALIMUMAB VERSUS SECUKINUMAB IN ACTIVE ANKYLOSING SPONDYLITIS: A MATCHING-ADJUSTED INDIRECT COMPARISON [J].
Betts, K. A. ;
Mittal, M. ;
Song, J. ;
Skup, M. ;
Joshi, A. .
ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 :98-99
[23]   Comparative Effectiveness of Bimekizumab and Ustekinumab in Patients with Psoriatic Arthritis at 52 Weeks Assessed Using a Matching-Adjusted Indirect Comparison [J].
Mease, Philip J. ;
Warren, Richard B. ;
Nash, Peter ;
Grouin, Jean-Marie ;
Lyris, Nikos ;
Taieb, Vanessa ;
Eells, Jason ;
McInnes, Iain B. .
RHEUMATOLOGY AND THERAPY, 2024, 11 (05) :1413-1423
[24]   Comparative Effectiveness of Bimekizumab and Guselkumab in Patients with Psoriatic Arthritis at 52 Weeks Assessed Using a Matching-Adjusted Indirect Comparison [J].
Warren, Richard B. ;
Mcinnes, Iain B. ;
Nash, Peter ;
Grouin, Jean-Marie ;
Lyris, Nikos ;
Willems, Damon ;
Taieb, Vanessa ;
Eells, Jason ;
Mease, Philip J. .
RHEUMATOLOGY AND THERAPY, 2024, 11 (03) :829-839
[25]   Comparative Effectiveness of Bimekizumab and Risankizumab in Patients with Psoriatic Arthritis at 52 Weeks Assessed Using a Matching-Adjusted Indirect Comparison [J].
Mease, Philip J. ;
Warren, Richard B. ;
Nash, Peter ;
Grouin, Jean-Marie ;
Lyris, Nikos ;
Willems, Damon ;
Taieb, Vanessa ;
Eells, Jason ;
Mcinnes, Iain B. .
RHEUMATOLOGY AND THERAPY, 2024, 11 (05) :1403-1412
[26]   SECUKINUMAB SHOWS HIGHER SYMPTOMATIC IMPROVEMENT VERSUS INFLIXIMAB IN PSORIATIC ARTHRITIS: COMPARATIVE EFFECTIVENESS UP TO 1 YEAR ASSESSED BY MATCHING-ADJUSTED INDIRECT COMPARISONS [J].
Strand, V ;
McInnes, I. ;
Thom, H. ;
Hunger, M. ;
Lopes, N. ;
Gandhi, K. ;
Jugl, S. M. .
VALUE IN HEALTH, 2017, 20 (09) :A935-A936
[27]   Comparative effectiveness of erenumab versus rimegepant for migraine prevention using matching-adjusted indirect comparison [J].
Mahon, Ronan ;
Tiwari, Santosh ;
Koch, Mirja ;
Ferraris, Matias ;
Betts, Keith A. ;
Wang, Yan ;
Gao, Sophie ;
Proot, Pascal .
JOURNAL OF COMPARATIVE EFFECTIVENESS RESEARCH, 2024, 13 (03)
[28]   Comparative effectiveness of ozanimod versus dimethyl fumarate: results of a matching-adjusted indirect comparison [J].
Cohan, S. ;
Kumar, J. ;
Arndorfer, S. ;
Zhu, X. ;
Zivkovic, M. ;
Tencer, T. .
MULTIPLE SCLEROSIS JOURNAL, 2020, 26 (3_SUPPL) :140-140
[29]   Comparison of Secukinumab Vs Adalimumab in a Cost per Responder Analysis Based on a Matching-Adjusted Indirect Comparison of Efficacy Data for the Treatment of Psoriatic Arthritis at 48 Weeks from the US Perspective [J].
Greenberg, Jeffrey D. ;
Nikoglou, Efthalia ;
Gunda, Praveen ;
Palmer, Jacqueline ;
Jugl, Steffen .
ARTHRITIS & RHEUMATOLOGY, 2016, 68
[30]   MATCHING-ADJUSTED INDIRECT COMPARISON OF IXEKIZUMAB VS. TOFACITINIB IN PSORIATIC ARTHRITIS [J].
Sapin, C. ;
Panni, T. ;
Meszaros, G. ;
Hill, J. ;
Hartz, S. .
VALUE IN HEALTH, 2020, 23 :S593-S593
12345